News Conference News TCT 2012 Positive Long-Term Results from LEADERS, BioFreedom FIM, ISAR-TEST 5 October 24, 2012
News Conference News TCT 2012 PEACE: Data Demonstrate Benefits of Plaque Identification in High-Risk Patients October 24, 2012
News Conference News TCT 2012 Repositionable Valves Found Safe, Effective in Two Trials October 24, 2012
News Industry News Elixir Medical Corporation Announces Outstanding Three-year Data from the EXCELLA II Randomized Clinical Trial for the CE Mark-Approved DESyne® System(2) October 24, 2012
News Conference News TCT 2012 Maintaining Successful Practice Depends on Changing Old Habits, Embracing CV Service Lines October 24, 2012
News Conference News TCT 2012 Tailored Clopidogrel Therapy Bests Prasugrel at Control of Platelet Reactivity in ACS October 24, 2012
News Industry News Elixir Medical Corporation Announces Outstanding Three-Year Data from the EXCELLA II Randomized Clinical Trial for the CE Mark-Approved DESyne® System October 24, 2012
News Conference News TCT 2012 Pre-PCI Statin Regimen Produces No Significant Effect on Troponin I Release October 24, 2012
News Industry News Reported at TCT 2012: InspireMD MGuard Stent Meets Primary Endpoint of MASTER Trial, Significantly Improving Prospects of Heart Attack Survival October 24, 2012